Invasive Breast Carcinoma Active Not Recruiting Phase 1 Trials for Trastuzumab (DB00072)

Also known as: Invasive carcinoma of breast / Breast cancer invasive NOS

IndicationStatusPhase
DBCOND0031787 (Invasive Breast Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01434303Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab OnlyTreatment